 |
市场调查报告书
商品编码
1461419
血管栓塞市场，按栓塞技术、应用、地理位置 - 规模、份额、前景和机会分析，2024 年 - 2031 年Vascular Embolization Market, By Embolization Technique, By Application, By Geography - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031 |
||||||
预计 2024 年全球血管栓塞市场价值为 19.329 亿美元，预计在预测期内（2024-2031 年）复合年增长率为 9.5%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年： | 2023年 | 2023/2024 年市场规模： | 19.329 亿美元 |
| 历史数据： | 2019年至2023年 | 预测期： | 2024年至2031年 |
| 预测期间 2023/2024 至 2030/2031 年复合成长率： | 9.50% | 2030/2031 价值预测： | 36.482 亿美元 |
血管栓塞是指栓子在血流中的通过和滞留。它是一种微创治疗，可阻塞一条或多条血管或异常血管通道。血管栓塞剂用于透过机械闭塞的方式急性阻止血管或血管区域的血流。这些药剂经由导管释放到血液中，以生物或机械方式闭塞目标血管；永久或暂时。血管栓塞剂的一些特征是成功率高、很少使用麻醉剂、恢復时间更快、感染风险最小、无疤痕。栓塞是介入放射学中常见且有效的手术。它是开放性手术的替代方案。
市场动态：
临床试验数量的增加以及研发的增加预计将在预测期内促进全球血管栓塞市场的成长。例如，2021 年 3 月，Instylla Inc. 报告了第一批治疗富血管肿瘤的关键 Embrace 水凝胶栓塞系统 (HES) 全球随机临床试验的患者入组。
2022 年 3 月，Instylla 宣布在《血管和介入放射学杂誌》(JVIR) 上发表 Embrace 水凝胶栓塞系统 (HES) 治疗富血管肿瘤的首次人体临床试验结果。研究表明，HES 透过阻断肿瘤血液供应，有效栓塞恶性和良性富血管肿瘤，技术上取得了成功，并且持续栓塞，如30 天影像追踪中所指出的那样，该研究治疗的所有8 名患者均如此。
研究的主要特点：
- 该报告对全球血管栓塞市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
- 它阐明了不同细分市场的潜在收入机会，并解释了该市场有吸引力的投资主张矩阵。
- 这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
- 它根据以下参数（例如公司亮点、产品组合、主要亮点、财务表现和策略）介绍了全球血管栓塞市场的主要参与者。
- 该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球血管栓塞市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和金融分析师。
- 利害关係人可以透过用于分析全球血管栓塞市场的各种策略矩阵轻鬆做出决策。
目录：
第一章：研究目标与假设
- 研究目标
- 假设
- 缩写
第 2 章：市场范围
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map (COM)
第 3 章：市场动态、法规与趋势分析
- 市场动态
- 血管疾病盛行率增加
- 与栓塞手术相关的併发症
- 血管栓塞装置的需求不断增加
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/批准
- PEST分析
- 波特的分析
- 併购场景
第 4 章：全球血管栓塞市场 - 冠状病毒 (COVID-19) 大流行的影响
- COVID-19 流行病学
- 供给面和需求面分析
- 经济影响
第 5 章：2019-2031 年全球血管栓塞市场（按栓塞技术）
- 介绍
- 捲取装置
- 非捲取装置
第 6 章：2019-2031 年全球血管栓塞市场（依应用）
- 介绍
- 週边血管疾病
- 肿瘤学
- 神经病学
- 泌尿科
- 其他应用
第 7 章：2019-2031 年全球血管栓塞市场（按地区）
- 介绍
- 北美洲
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东和非洲
- 世界其他地区
第 8 章：竞争格局
- Shape Memory Medical Inc.
- Terumo Corp
- Penumbra Inc.
- Abbott Laboratories
- Stryker Corporation
- Cook Medical
- Medtronic PLC
- Merit Medical Systems Inc.
- Johnson and Johnson (Cerenovus)
- Boston Scientific Corporation
第 9 章：分析师建议
- 命运之轮
- 分析师观点
- 连贯的机会图
第 10 章：部分
- 参考
- 研究方法论
The global vascular embolization market is estimated to be valued at USD 1,932.9 Mn in 2024 and is expected to exhibit a CAGR of 9.5% during the forecast period (2024-2031).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2023/2024: | US$ 1,932.9 Mn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2023/2024 to 2030/2031 CAGR: | 9.50% | 2030/2031 Value Projection: | US$ 3,648.2 Mn |
Vascular embolization refers to the passage and lodging of an embolus within the bloodstream. It is a minimally invasive treatment that blocks one or more blood vessels or abnormal vascular channels. Vascular embolization agents are used to acutely stop flow in blood vessel or vascular area by the means of mechanical occlusion. These agents are released into the blood through a catheter to biologically or mechanically occlude the target vessel; permanently or temporarily. High success rate, rare use of anesthetics, faster recovery time, minimal risk of infection, and no scarring are some features of vascular embolization agents. Embolization is a common and effective procedure in interventional radiology. It is an alternative to open surgery.
Market Dynamics:
Increasing number of clinical trials and increase in research and development is expected to augment the growth of the global vascular embolization market during the forecast period. For instance, in March 2021, Instylla Inc. reported the enrollment of the first patients in the pivotal Embrace Hydrogel Embolic System (HES) global randomized clinical trial for the treatment of hypervascular tumors.
In March 2022, Instylla announced the publication of results from the first-in-human clinical trial of Embrace Hydrogel Embolic System (HES) for the treatment of hypervascular tumors, in the Journal of Vascular and Interventional Radiology (JVIR). The study demonstrated that HES effectively embolized malignant & benign hypervascular tumors by blocking tumor blood supply with technical success and persistent embolization, as noted in imaging follow-up at 30-days, in all eight patients treated on this study.
Key features of the study:
- This report provides in-depth analysis of the global vascular embolization market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global vascular embolization market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Shape Memory Medical Inc., Terumo Corp, Abbott Laboratories, Stryker Corporation, Cook Medical, Medtronic PLC, Merit Medical Systems Inc., Penumbra Inc., Johnson and Johnson (Cerenovus), and Boston Scientific Corporation, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global vascular embolization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vascular embolization market.
Detailed Segmentation:
- Global Vascular Embolization Market, By Embolization Technique:
- Coiling Devices
- Non-coiling Devices
- Global Vascular Embolization Market, By Application:
- Peripheral Vascular Disease
- Oncology
- Neurology
- Urology
- Other Applications
- Global Vascular Embolization Market, By Geography:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
- Key Players Insights
- Shape Memory Medical Inc.
- Terumo Corp
- Penumbra Inc.
- Abbott Laboratories
- Stryker Corporation
- Cook Medical
- Medtronic PLC
- Merit Medical Systems Inc.
- Johnson and Johnson (Cerenovus)
- Boston Scientific Corporation
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Embolization Technique
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing prevalence of vascular diseases
- Complications associated with embolization procedures
- Increasing demand for vascular embolization devices
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Vascular Embolization Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Vascular Embolization Market, By Embolization Technique, 2019-2031, (US$ Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Coiling Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Non-coiling Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
6. Global Vascular Embolization Market, By Application, 2019-2031, (US$ Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Peripheral Vascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Urology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
7. Global Vascular Embolization Market, By Region, 2019-2031, (US$ Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
- Rest of the World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
8. Competitive Landscape
- Shape Memory Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Penumbra Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cook Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merit Medical Systems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson (Cerenovus)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. Section
- References
- Research Methodology
- About Us and Sales Contact
